Taken together, our results suggest that CLDN3 and CLDN4 serve to maintain the expression of E-cadherin which acts as a central modulator of EMT in the ovarian cancer cells via a pathway involving PI3K/Akt and EMT transcription factor Twist. Here, AKT1 is linked to ovarian carcinoma.